BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4130147)

  • 21. Release of a low molecular weight Fc-like fragment on reduction of water-insoluble IgG myeloma proteins.
    Morris GG; Osterland CK; Chaplin H
    Vox Sang; 1974; 27(4):273-86. PubMed ID: 4278247
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolation of IgA and of a fast subfraction of IgG from human placenta extract.
    Byszewska E; Zakrzewski K
    Acta Biochim Pol; 1974; 21(3):365-75. PubMed ID: 4216218
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of biclonal myeloma (IgG-IgA)].
    Cagianelli MA; Lofaro A; Messina F; Parenti R; Beati A
    Arch Maragliano Patol Clin; 1976; 32():101-7. PubMed ID: 1053285
    [No Abstract]   [Full Text] [Related]  

  • 24. [Myelomatous paraproteinemia of the IgA or IgG type and blood lipids].
    Clerc M; Triquet A; Martine J
    Bull Soc Pathol Exot Filiales; 1974; 67(1):101-8. PubMed ID: 4219146
    [No Abstract]   [Full Text] [Related]  

  • 25. A human IgG myeloma protein with anti- 2 macroglobulin antibody activity.
    Seligmann M; Sassy C; Chevalier A
    J Immunol; 1973 Jan; 110(1):85-90. PubMed ID: 4631075
    [No Abstract]   [Full Text] [Related]  

  • 26. [Letter: An IgA paraprotein in dogs].
    Goudswaard J; van Ooyen PG; Slappendel RJ; v d Watering CC; Hendriks HJ
    Tijdschr Diergeneeskd; 1975 Apr; 100(7):395-7. PubMed ID: 1145605
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of subclass-related F(ab)2, Fab-c and Fch fragments obtainined by short papain digestion of human IgG myeloma proteins.
    Michaelsen TE; Natvig JB
    Scand J Immunol; 1973; 2(3):299-312. PubMed ID: 4203731
    [No Abstract]   [Full Text] [Related]  

  • 28. [The presence in some human sera of anti-IgD antibodies (author's transl)].
    Rivat C; Rivat L; Ropartz C
    Ann Immunol (Paris); 1974; 125(3):427-37. PubMed ID: 4212859
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of idiotypic determinants on human monoclonal proteins with specific rabbit antisera and hemagglutination-inhibition.
    Wells JV; Wang AC; Thornsvard CT; Schanfield MS; Bleumers JF; Fudenberg HH
    J Immunol; 1973 Sep; 111(3):841-6. PubMed ID: 4200367
    [No Abstract]   [Full Text] [Related]  

  • 30. Double myeloma. Production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line.
    Rudders RA; Yakulis V; Heller P
    Am J Med; 1973 Aug; 55(2):215-21. PubMed ID: 4124689
    [No Abstract]   [Full Text] [Related]  

  • 31. Myeloma producing nonsecretory IgM and secretory IgG.
    Stein H; Kaiserling E
    Scand J Haematol; 1974; 12(4):274-83. PubMed ID: 4134805
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM.
    Yagi Y; Pressman D
    J Immunol; 1973 Feb; 110(2):335-44. PubMed ID: 4119246
    [No Abstract]   [Full Text] [Related]  

  • 33. Interspecies occurrence of immunoglobulin antigens reactive with anti-allotype antisera.
    Rodkey LS; Conrad AH
    J Immunol; 1972 Aug; 109(2):342-7. PubMed ID: 4114827
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera.
    Morell A; Skvaril F; Steinberg AG; Van Loghem E; Terry WD
    J Immunol; 1972 Jan; 108(1):195-206. PubMed ID: 4622006
    [No Abstract]   [Full Text] [Related]  

  • 35. [Isolation of antisera to different IgA determinants and an analysis of the antigenic structure of human monoclonal IgA].
    German GP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):52-8. PubMed ID: 2412371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of immunogenicity of a BALB-c myeloma protein in BALB-c mice.
    Peaker PJ; Cicurei L; Nisonoff A
    J Immunol; 1974 Sep; 113(3):791-7. PubMed ID: 4213082
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VH and L-chain allotype determinants of rabbit IgG and IgA estimated by a semi-automatic, modified Farr-type radioimmunoassay;
    Jensenius JC
    Eur J Immunol; 1977 Feb; 7(2):99-103. PubMed ID: 68886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diclonal and multiple gammopathies.
    Ottó S; Puskás E; Medgyesi GA; Gergely J
    Haematologia (Budap); 1972; 6(4):471-87. PubMed ID: 4206675
    [No Abstract]   [Full Text] [Related]  

  • 40. [Amino acid makeup of the immunoglobulin characteristic of G-myelomas].
    Cherniavskiĭ EI; Protsenko BA; Korotkoruchko VP; Sen'ko LN
    Ukr Biokhim Zh; 1974; 46(3):320-3. PubMed ID: 4836935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.